Decrease in basal ganglia grey matter density associated with atypical antipsychotic treatment in schizophrenia patients.
Emmanuel
E
Stip
Adham
A
Mancini-Marïe
Cherine
C
Fahim
Lahcen Ait
LA
Bentaleb
Genevieve
G
Létourneau
Stéphane
S
Potvin
D000328:Adult; D001479:Basal Ganglia / Q000187:drug effects* / Q000473:pathology; D002421:Caudate Nucleus / Q000187:drug effects / Q000473:pathology; D003987:Dibenzothiazepines / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007091:Image Processing, Computer-Assisted; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D000069348:Quetiapine Fumarate; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*
D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate